FDA Watch: OraSure’s Collection Device for Cobas STI Testing Receives Approval
At-home sample collections can be mailed to a clinical laboratory
At-home sample collections can be mailed to a clinical laboratory
On Oct. 10, 2019, the FDA finalized guidance on an optional streamlined submission process to determine whether
From – National Intelligence Report
The FDA has apparently set its enforcement sights on Laboratory Developed Tests (LDTs) that claim to predict…